KNIGHTSCOPE INC-A (KSCP)

US49907V1026 - Common Stock

13.35  +0.27 (+2.06%)

After market: 13.04 -0.31 (-2.32%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KSCP. KSCP was compared to 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of KSCP have multiple concerns. KSCP is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year KSCP has reported negative net income.
KSCP had a negative operating cash flow in the past year.
KSCP had negative earnings in each of the past 5 years.
In the past 5 years KSCP always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -117.06%, KSCP is doing worse than 95.18% of the companies in the same industry.
Looking at the Return On Equity, with a value of -257.15%, KSCP is doing worse than 90.36% of the companies in the same industry.
Industry RankSector Rank
ROA -117.06%
ROE -257.15%
ROIC N/A
ROA(3y)-155.08%
ROA(5y)-153.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KSCP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KSCP has been reduced compared to 1 year ago.
KSCP has less shares outstanding than it did 5 years ago.
The debt/assets ratio for KSCP has been reduced compared to a year ago.

2.2 Solvency

KSCP has an Altman-Z score of -10.73. This is a bad value and indicates that KSCP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -10.73, KSCP is doing worse than 95.18% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that KSCP is not too dependend on debt financing.
KSCP has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z -10.73
ROIC/WACCN/A
WACC8.74%

2.3 Liquidity

A Current Ratio of 1.21 indicates that KSCP should not have too much problems paying its short term obligations.
KSCP has a worse Current ratio (1.21) than 68.67% of its industry peers.
A Quick Ratio of 0.84 indicates that KSCP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.84, KSCP is doing worse than 78.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.84

5

3. Growth

3.1 Past

The earnings per share for KSCP have decreased strongly by -1688.17% in the last year.
Looking at the last year, KSCP shows a quite strong growth in Revenue. The Revenue has grown by 16.66% in the last year.
The Revenue has been growing by 34.20% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1688.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)16.66%
Revenue growth 3Y56.63%
Revenue growth 5Y34.2%
Sales Q2Q%-10.1%

3.2 Future

The Earnings Per Share is expected to grow by 19.90% on average over the next years. This is quite good.
The Revenue is expected to grow by 15.70% on average over the next years. This is quite good.
EPS Next Y31.25%
EPS Next 2Y19.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.51%
Revenue Next 2Y15.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

KSCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KSCP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

KSCP's earnings are expected to grow with 19.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

KSCP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KNIGHTSCOPE INC-A

NASDAQ:KSCP (12/20/2024, 8:21:32 PM)

After market: 13.04 -0.31 (-2.32%)

13.35

+0.27 (+2.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners3.96%
Inst Owner Change-96.79%
Ins Owners0.8%
Ins Owner Change0%
Market Cap56.20M
Analysts82.86
Price Target191.25 (1332.58%)
Short Float %8.07%
Short Ratio0.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.38%
Min EPS beat(2)-30.72%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-15.74%
Min EPS beat(4)-30.72%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)11.99%
Min Revenue beat(2)-33.04%
Max Revenue beat(2)57.01%
Revenue beat(4)3
Avg Revenue beat(4)8.62%
Min Revenue beat(4)-33.04%
Max Revenue beat(4)57.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4900%
EPS NY rev (1m)0%
EPS NY rev (3m)-4900%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.77
P/FCF N/A
P/OCF N/A
P/B 5.03
P/tB 7.16
EV/EBITDA N/A
EPS(TTM)-15.5
EYN/A
EPS(NY)-9.18
Fwd EYN/A
FCF(TTM)-6.08
FCFYN/A
OCF(TTM)-6.08
OCFYN/A
SpS2.8
BVpS2.65
TBVpS1.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -117.06%
ROE -257.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-155.08%
ROA(5y)-153.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.04%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.84
Altman-Z -10.73
F-Score2
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)11.17%
Cap/Depr(5y)6.98%
Cap/Sales(3y)3.01%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1688.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
EPS Next Y31.25%
EPS Next 2Y19.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.66%
Revenue growth 3Y56.63%
Revenue growth 5Y34.2%
Sales Q2Q%-10.1%
Revenue Next Year-5.51%
Revenue Next 2Y15.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.1%
OCF growth 3YN/A
OCF growth 5YN/A